<?xml version="1.0" encoding="iso-8859-1"?>
<!-- generator="FeedCreator 1.7.2" -->
<rss version="2.0">
    <channel>
        <title>MedWorm Tags: hcv</title>
        <description>MedWorm provides a medical RSS filtering service. Over 6000 RSS medical sources are combined and output via different filters. This feed contains the latest medical blog items that have been tagged with 'hcv'.</description>
        <link><![CDATA[http://www.medworm.com/rss/search.php?qu=%22hcv%22&t=%22hcv%22&r=Exact&o=d&f=tag]]></link>
        <lastBuildDate>Sat, 03 Sep 2011 02:21:03 +0100</lastBuildDate>
        <item>
            <title>TWiV 141: Mickey gets HCV</title>
            <link>http://www.medworm.com/index.php?rid=5018725&amp;cid=t_128449_139_f&amp;fid=38879&amp;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FVirologyBlog%2F%7E3%2F2aql2DLq09Q%2F</link>
            <description>Hosts: Vincent Racaniello, Rich Condit, Dickson Despommier, Alan Dove, and Matt Evans
Matt Evans joins Vincent, Rich, Dickson, and Alan to deconstruct a mouse model for hepatitis C virus infection.

Click the arrow above to play, or right-click to download TWiV #141 (117 MB .mp3, 97 minutes).
Subscribe to TWiV (free) in iTunes , at the Zune Marketplace, by the RSS feed, by email, or listen on your mobile device with the Microbeworld app.
Links for this episode:

Mouse model for HCV infection (Nature)
Commentary on HCV mouse model (Nature)
Matt Evans on the Wall Street Journal Report
TWiV on Facebook
Letters read on TWiV 141

Weekly Science Picks
Matt &amp;#8211; Benezra letter to NIH (pdf); (NIH response and Nature commentary)
Dickson &amp;#8211; The Big Thirst by Charles Fishman
Alan &amp;#8211; Ea...</description>
            <author>virology blog</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5018725</comments>
            <pubDate>Sun, 10 Jul 2011 15:39:17 +0100</pubDate>
            <guid isPermaLink="false">5018725</guid>        </item>
        <item>
            <title>TWiV 137: Look what the dog dragged in</title>
            <link>http://www.medworm.com/index.php?rid=4933163&amp;cid=t_128449_139_f&amp;fid=38879&amp;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FVirologyBlog%2F%7E3%2FUcJTKTXAtMw%2F</link>
            <description>Hosts: Vincent Racaniello, Alan Dove, Rich Condit, Dickson Despommier, Amit Kapoor, and Ian Lipkin
The TWiV team speaks with Amit Kapoor and Ian Lipkin about how they discovered canine hepacivirus, and its implications for the origin and evolution of hepatitis C virus.

Click the arrow above to play, or right-click to download TWiV #137 (69 MB .mp3, 96 minutes).
Subscribe to TWiV (free) in iTunes , at the Zune Marketplace, by the RSS feed, by email, or listen on your mobile device with the Microbeworld app.
Links for this episode:

Characterization of canine hepacivirus (PNAS)
Humanized mouse model for HCV (EurekAlert!)
Summary of CHV study from Mailman School of Public Health
Center for Infection and Immunity at Columbia University
TWiV on Facebook
Letters read on TWiV 137

Weekly Sc...</description>
            <author>virology blog</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4933163</comments>
            <pubDate>Sun, 12 Jun 2011 22:38:40 +0100</pubDate>
            <guid isPermaLink="false">4933163</guid>        </item>
        <item>
            <title>Canine hepacivirus, a relative of hepatitis C virus</title>
            <link>http://www.medworm.com/index.php?rid=4871355&amp;cid=t_128449_139_f&amp;fid=38879&amp;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FVirologyBlog%2F%7E3%2F2LnQ9MMrxr0%2F</link>
            <description>Contemporary human viruses most likely originated by cross-species transmission from non-human animals. Examples include HIV-1, which crossed from chimpanzees to humans, and SARS coronavirus, which originated in bats. Since the 1989 discovery of hepatitis C virus (classified as a hepacivirus in the family Flaviviridae) the origin of the virus been obscure. During the characterization of respiratory infections of domestic dogs, a virus was discovered that is the most genetically similar animal virus homolog of HCV.
HCV is a substantial human pathogen: 200 million people worldwide are chronically infected and are at risk for the development of hepatocellular carcinoma. The source of HCV is unknown because there are no closely related animal virus homologs, but the hunt for related viruses ha...</description>
            <author>virology blog</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4871355</comments>
            <pubDate>Thu, 26 May 2011 02:02:42 +0100</pubDate>
            <guid isPermaLink="false">4871355</guid>        </item>
        <item>
            <title>TWiV 130: Rhino tracking, wrestling pox, and HCV in the crosshairs</title>
            <link>http://www.medworm.com/index.php?rid=4747270&amp;cid=t_128449_139_f&amp;fid=38879&amp;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FVirologyBlog%2F%7E3%2F9ScghR9Ji_c%2F</link>
            <description>Hosts: Vincent Racaniello, Alan Dove, and Rich Condit
Vincent, Alan, and Rich discuss growth in culture of newly identified rhinovirus C, vaccinia transmission among wrestlers and martial artists, and results of phase III clinical trial of boceprevir, a new inhibitor of hepatitis C virus replication.

Click the arrow above to play, or right-click to download TWiV #130 (45 MB .mp3, 93 minutes).
Subscribe to TWiV (free) in iTunes , at the Zune Marketplace, by the RSS feed, by email, or listen on your mobile device with the Microbeworld app.
Links for this episode:

Growth of newly identified rhinovirus C (Nature Medicine)
Global distribution of rhinovirus C (EID)
Vaccinia transmission among wrestlers (EID)
Vaccine transmission in a martial arts gym (EID)
Boceprevir for untreated HCV in...</description>
            <author>virology blog</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4747270</comments>
            <pubDate>Sun, 24 Apr 2011 14:40:35 +0100</pubDate>
            <guid isPermaLink="false">4747270</guid>        </item>
        <item>
            <title>Reductions in Drinking for Hep C Patients</title>
            <link>http://www.medworm.com/index.php?rid=4025781&amp;cid=t_128449_151_f&amp;fid=35805&amp;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2Ftwelvestepfacilitation%2FwAgT%2F%7E3%2Fca7eOYibSuM%2F</link>
            <description>DISCUSSION: Brief treatment addressing heavy drinking delivered by hepatitis clinicians with psychiatric-specialist follow-up was associated with abstinence or a significant reduction in alcohol consumption in over 50% of patients.
Eric Dieperink, M.D., Samuel B. Ho, M.D., Sara Heit, M.S., R.N., C.N.S., Janet M. Durfee, R.N., M.S.N., APRN, Paul Thuras, Ph.D., and Mark L. Willenbring, M.D. Psychosomatics 51:149-156, March-April 2010

See also
Hepatitis C – Does sexual transmission occur?
Counselor Magazine&amp;#8217;s Addiction Professional Reference Guide
Disturbing Denial
Improving Treatment Compliance
Wernicke-Korsakoff Syndrome

Random ArticlesRecovering Alcoholics Effective in Helping OthersFamilies, mental health &amp;#038; alcohol abuseAlcohol Across the LifespanBrief-TSF DescriptionPrinci...</description>
            <author>Twelve Step Facilitation.com</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4025781</comments>
            <pubDate>Thu, 30 Sep 2010 07:04:14 +0100</pubDate>
            <guid isPermaLink="false">4025781</guid>        </item>
        <item>
            <title>TWiV 97: California virology</title>
            <link>http://www.medworm.com/index.php?rid=3935736&amp;cid=t_128449_139_f&amp;fid=38879&amp;url=http%3A%2F%2Fmedia.rawvoice.com%2Fpmn_twiv%2Fwww.twiv.tv%2FTWiV097.mp3</link>
            <description>Hosts: Vincent Racaniello, Peter Sarnow, and Bert Semler
On episode #97 of the podcast This Week in Virology, Vincent visited Peter Sarnow and Bert Semler during a trip to California, and spoke with them about their work on internal ribosome entry, and the requirement for a cellular microRNA for hepatitis C virus replication.
Download TWiV #97 (66 MB .mp3, 91 minutes)
Subscribe to TWiV (free) in iTunes , at the Zune Marketplace, by the RSS feed, or by email, or listen on your mobile device with Stitcher Radio.
Links for this episode:

Eukaryotic mRNAs that might contain an IRES (PNAS)
Modulation of HCV RNA abundance by a liver-specific microRNA (Science)
Viral small RNAs (PLoS Pathogens)
Bridging IRES elements to the translation apparatus (Biochim Biophys Acta)
A nucleo-cytoplasmic SR pro...</description>
            <author>virology blog</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3935736</comments>
            <pubDate>Sun, 05 Sep 2010 22:18:41 +0100</pubDate>
            <guid isPermaLink="false">3935736</guid>        </item>
        <item>
            <title>TWiV 86: Dark matter with Dr. Eric Delwart</title>
            <link>http://www.medworm.com/index.php?rid=3656763&amp;cid=t_128449_139_f&amp;fid=38879&amp;url=http%3A%2F%2Fmedia.rawvoice.com%2Fpmn_twiv%2Fwww.twiv.tv%2FTWiV086.mp3</link>
            <description>Hosts: Vincent Racaniello, Rich Condit, and Eric Delwart
In episode #86 of the podcast This Week in Virology, Vincent and Rich travel to the Blood Systems Research Institute in San Francisco to speak with Eric Delwart about his work on virus discovery.
This episode is sponsored by Data Robotics Inc. Use the promotion code TWIVPOD to receive $75-$500 off a Drobo.
Receive 50% off the manufacturers suggested retail price of a Drobo S or FS at drobostore.com. Just fill out the questionnaire here.
Download TWiV #86 (59 MB .mp3, 81 minutes)
Subscribe to TWiV (free) in iTunes , at the Zune Marketplace, by the RSS feed, or by email, or listen on your mobile device with Stitcher Radio.
Links for this episode:

List of Dr. Delwart&amp;#8217;s open-access journal articles (pdf) &amp;#8211; to find each on...</description>
            <author>virology blog</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3656763</comments>
            <pubDate>Sun, 13 Jun 2010 14:41:40 +0100</pubDate>
            <guid isPermaLink="false">3656763</guid>        </item>
        <item>
            <title>A new target for hepatitis C virus</title>
            <link>http://www.medworm.com/index.php?rid=3648231&amp;cid=t_128449_139_f&amp;fid=38879&amp;url=http%3A%2F%2Fwww.virology.ws%2Ffib60.mp3</link>
            <description>When infection with hepatitis C virus goes from acute to chronic, severe liver disease may occur which requires organ transplantation. Nearly 200 million people are chronically infected with HCV, necessitating approaches to preventing and treating infections. No HCV vaccine is available, and current antiviral therapy consists of administration of interferon plus ribavirin, a combination that is effective about half the time and is associated with undesirable side effects. New antiviral compounds that target a viral protease and RNA polymerase are currently in clinical trials may eventually reach the market. But our experience with HIV-1 has shown that combinations of three drugs are the most effective for derailing the emergences of drug resistant viruses. The third target for HCV could be...</description>
            <author>virology blog</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3648231</comments>
            <pubDate>Wed, 09 Jun 2010 16:17:13 +0100</pubDate>
            <guid isPermaLink="false">3648231</guid>        </item>
        <item>
            <title>TWiV 85: Hepatitis C virus with Professor Michael Gale</title>
            <link>http://www.medworm.com/index.php?rid=3635504&amp;cid=t_128449_139_f&amp;fid=38879&amp;url=http%3A%2F%2Fmedia.rawvoice.com%2Fpmn_twiv%2Fwww.twiv.tv%2FTWiV085.mp3</link>
            <description>Hosts: Vincent Racaniello and Michael Gale
On episode 85 of the podcast This Week in Virology, Vincent and Michael Gale discuss the origin, pathogenesis, prevention, of hepatitis C virus, and how it evades innate immune responses.
This episode is sponsored by Data Robotics Inc. Use the promotion code TWIVPOD to receive $75-$500 off a Drobo.
Download TWiV #85 (40 MB .mp3, 56 minutes)
Subscribe to TWiV (free) in iTunes , at the Zune Marketplace, by the RSS feed, or by email, or listen on your mobile device with Stitcher Radio.
Links for this episode:

The Gale Laboratory at the University of Washington
Incredible view from the Gale laboratory (jpg)
Evasion and disruption of innate immune signalling by hepatitis C and West Nile viruses (review)
New potent HCV inhibitor
HCV virion and genome s...</description>
            <author>virology blog</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3635504</comments>
            <pubDate>Sun, 06 Jun 2010 15:33:31 +0100</pubDate>
            <guid isPermaLink="false">3635504</guid>        </item>
        <item>
            <title>Futures in Biotech 60: Do you come to this cave often?</title>
            <link>http://www.medworm.com/index.php?rid=3595350&amp;cid=t_128449_139_f&amp;fid=38879&amp;url=http%3A%2F%2Fwww.podtrac.com%2Fpts%2Fredirect.mp3%2Ftwit.cachefly.net%2Ffib0060.mp3</link>
            <description>I joined Marc Pelletier on episode 60 of Futures in Biotech for a conversation with Dave Brodbeck, George Farr, and Andre Nantel. We talked about primate face recognition, discovery of a new antiviral compound to treat hepatitis C virus infection, changing the length of a codon from three to four bases, and the sequence of the neanderthal genome.
Download FiB #60 (44 MB .mp3, 91 minutes)
Video courtesy of Team ODTV
				
				
Download video (179 MB .mp4) (Source: virology blog)</description>
            <author>virology blog</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3595350</comments>
            <pubDate>Tue, 25 May 2010 10:38:37 +0100</pubDate>
            <guid isPermaLink="false">3595350</guid>        </item>
        <item>
            <title>Reductions in Drinking for Hep C Patients</title>
            <link>http://www.medworm.com/index.php?rid=3408640&amp;cid=t_128449_151_f&amp;fid=35805&amp;url=http%3A%2F%2Ftwelvestepfacilitation.com%2Freductions-in-drinking-for-hep-c-patients%2F</link>
            <description>DISCUSSION: Brief treatment addressing heavy drinking delivered by hepatitis clinicians with psychiatric-specialist follow-up was associated with abstinence or a significant reduction in alcohol consumption in over 50% of patients.
Eric Dieperink, M.D., Samuel B. Ho, M.D., Sara Heit, M.S., R.N., C.N.S., Janet M. Durfee, R.N., M.S.N., APRN, Paul Thuras, Ph.D., and Mark L. Willenbring, M.D. Psychosomatics 51:149-156, March-April 2010

See also
Hepatitis C – Does sexual transmission occur?
Counselor Magazine&amp;#8217;s Addiction Professional Reference Guide
Disturbing Denial
Improving Treatment Compliance
Wernicke-Korsakoff Syndrome


Related Reading:




       Share/SaveRandom ArticlesPatient Mental Illness in a Dental School ClinicComorbid anxiety or alcohol disorderAA and recovery from alc...</description>
            <author>Twelve Step Facilitation.com</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3408640</comments>
            <pubDate>Fri, 26 Mar 2010 09:34:46 +0100</pubDate>
            <guid isPermaLink="false">3408640</guid>        </item>
        <item>
            <title>Hepatitis C – Does sexual transmission occur?</title>
            <link>http://www.medworm.com/index.php?rid=3327306&amp;cid=t_128449_151_f&amp;fid=35818&amp;url=http%3A%2F%2Frecoveryissexy.com%2Fhepatitis-c-does-sexual-transmission-occur%2F</link>
            <description>Jaundice
Although there is some uncertainty about hepatitis C (also called hep C) being transmitted sexually, it’s not classified as an STI (sexually transmissible infection). General scientific knowledge supports this position.
Some people, unable to identify any other risk factors, believe they may have contracted hep C sexually. Additionally, some research suggests that a small percentage of people do contract hep C through sexual contact. Thus, transmission of hep C during sex is seen as possible but is believed to be rare.
General transmission of HCV
Hep C is most commonly transmitted through blood-to-blood contact, ie. when the blood of someone with the virus enters the bloodstream of someone else. This can occur through: sharing needles or syringes or any other drug injecting equi...</description>
            <author>Recovery Is Sexy.com</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3327306</comments>
            <pubDate>Tue, 02 Mar 2010 04:54:39 +0100</pubDate>
            <guid isPermaLink="false">3327306</guid>        </item>
        <item>
            <title>Hepatitis C &amp; Alcohol</title>
            <link>http://www.medworm.com/index.php?rid=3153649&amp;cid=t_128449_151_f&amp;fid=35818&amp;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FRecoveryIsSexycom%2F%7E3%2FiLoNIU_9hRs%2F</link>
            <description>Hepatitis C is a liver disease caused by the hepatitis C virus (HCV).
People usually become infected after coming in contact with blood from an infected person.
Sharing needles or other equipment for injecting drugs is the most common way of spreading HCV. The disease also can be spread by sexual contact.
About 4 million people in the [...] (Source: Recovery Is Sexy.com)</description>
            <author>Recovery Is Sexy.com</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3153649</comments>
            <pubDate>Thu, 07 Jan 2010 13:20:57 +0100</pubDate>
            <guid isPermaLink="false">3153649</guid>        </item>
        <item>
            <title>Hepatitis C – Does sexual transmission occur?</title>
            <link>http://www.medworm.com/index.php?rid=3115290&amp;cid=t_128449_151_f&amp;fid=35818&amp;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FRecoveryIsSexycom%2F%7E3%2F9A4CaEku_i4%2F</link>
            <description>Jaundice
Although there is some uncertainty about hepatitis C (also called hep C) being transmitted sexually, it’s not classified as an STI (sexually transmissible infection). General scientific knowledge supports this position.
Some people, unable to identify any other risk factors, believe they may have contracted hep C sexually. Additionally, some research suggests that a small percentage of people do contract hep C through sexual contact. Thus, transmission of hep C during sex is seen as possible but is believed to be rare.
General transmission of HCV
Hep C is most commonly transmitted through blood-to-blood contact, ie. when the blood of someone with the virus enters the bloodstream of someone else. This can occur through: sharing needles or syringes or any other drug injecting equi...</description>
            <author>Recovery Is Sexy.com</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3115290</comments>
            <pubDate>Wed, 23 Dec 2009 12:46:24 +0100</pubDate>
            <guid isPermaLink="false">3115290</guid>        </item>
        <item>
            <title>World Hepatitis Day blog</title>
            <link>http://www.medworm.com/index.php?rid=2442311&amp;cid=t_128449_132_f&amp;fid=37823&amp;url=http%3A%2F%2Fathena.bioc.uvic.ca%2Fnode%2F1034</link>
            <description>In the World Hepatitis Day blog ahead of the formal publication of their Perspective article in PLoS Medicine, Paul Klenerman, Vicki Fleming and Ellie Barnes of the University of Oxford describe research by Christian Drosten and colleagues about a new low-cost diagnostic test for Hepatitis C for use in developing countries. The research was recently published in PLoS Medicine. (Source: VBRC Blog)</description>
            <author>VBRC Blog</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2442311</comments>
            <pubDate>Tue, 26 May 2009 00:07:04 +0100</pubDate>
            <guid isPermaLink="false">2442311</guid>        </item>
        <item>
            <title>HCV Infection vs Ethnic and Geographical HLA Associations</title>
            <link>http://www.medworm.com/index.php?rid=2390177&amp;cid=t_128449_132_f&amp;fid=37823&amp;url=http%3A%2F%2Fathena.bioc.uvic.ca%2Fnode%2F1017</link>
            <description>Hepatitis C virus (HCV) has infected more than 200 million individuals globally. Cellular immunity is believed to play a central role in the control of HCV infection. To elicit an adaptive cellular immune response, HCV antigens are processed into peptides and bind human leukocyte antigen (HLA). Once the HLA are recognized they can elicit a T cell response that can either directly lead to killing of the infected cell or cytokine secretion, respectively.
read more (Source: VBRC Blog)</description>
            <author>VBRC Blog</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2390177</comments>
            <pubDate>Thu, 07 May 2009 00:57:08 +0100</pubDate>
            <guid isPermaLink="false">2390177</guid>        </item>
        <item>
            <title>HCV Antiviral Biotech Race</title>
            <link>http://www.medworm.com/index.php?rid=2349276&amp;cid=t_128449_132_f&amp;fid=37823&amp;url=http%3A%2F%2Fathena.bioc.uvic.ca%2Fnode%2F998</link>
            <description>Chronic hepatitis C is the most common blood-borne infection in the US and is four times more common than HIV. An estimated 170 million people worldwide—3% of the global population—are infected, and up to 4 million acquire the infection each year. To eliminate detectable virus from the blood, current standard of care for hepatitis C patients is a combination of PEG-IFN-&amp;alpha; and ribavirin, a nucleoside analog with antiviral activity.
read more (Source: VBRC Blog)</description>
            <author>VBRC Blog</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2349276</comments>
            <pubDate>Fri, 17 Apr 2009 00:30:04 +0100</pubDate>
            <guid isPermaLink="false">2349276</guid>        </item>
        <item>
            <title>Multiplo: A Rapid HIV/HCV Test That Is Desperately Needed</title>
            <link>http://www.medworm.com/index.php?rid=1173290&amp;cid=t_128449_135_f&amp;fid=35272&amp;url=http%3A%2F%2Fslimconomy.blogspot.com%2F2008%2F01%2Fmultiplo-rapid-hivhcv-test-that-is.html</link>
            <description>Hepatitis C or HCV. A liver disease, and a rather stealthy one at that. It can take up residence like an illegal alien in your liver and quietly munch away on your liver for up to 10 years before you even realize it's there. Kind of like HIV. Like HIV, HCV shares the same transmission routes, even in perinatal transmission. There is increasing research that shows more and more incidences of co-infection of HIV and HCV. In a small study last year at Children's Hospital at Montefiore Medical Center in the Bronx last year, they found that 13 of the 288 children studied were co-infected with HIV and HCV or HBV. That's just one small study in New York. Now there could soon be a rapid HIV/HCV test to help detect coinfection - which would doubtless save many a baby's life.Those with HIV are also ...</description>
            <author>Slimconomy</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1173290</comments>
            <pubDate>Thu, 24 Jan 2008 02:14:00 +0100</pubDate>
            <guid isPermaLink="false">1173290</guid>        </item>
        <item>
            <title>Peregrine Pharmaceuticals Gives 1st Dose of Bavituximab</title>
            <link>http://www.medworm.com/index.php?rid=941863&amp;cid=t_128449_97_f&amp;fid=35050&amp;url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FPharmaGazette%2F%7E3%2F168057299%2Fperegrine_pharmaceuticals_give.html</link>
            <description>Peregrine Pharmaceuticals Inc. (Nasdaq: PPHM) announced that the first patient in their clinical trial has been dosed with Bavituximab.&amp;nbsp; Peregrine developed Bavituximab&amp;nbsp;as a&amp;nbsp;targeted therapy for patients infected with hepatitis c virus infection (HCV) and human immunodeficiency virus (HIV).The trial is being conducted at Saint Michael&amp;#39;s Medical Center in Newark, N.J. by Dr, Stephan Smith. &amp;quot;We believe that bavituximab has the potential to act on both HCV and HIV infections, and this trial gives us our first opportunity to assess the drug&amp;#39;s anti-viral activity in this underserved group of patients&amp;quot; said Steven W. King, president and CEO of Peregrine.The trial, conducted on 24 patients that are chronically infected with HCV and HIV, consists of ascending dose ...</description>
            <author>PharmaGazette</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=941863</comments>
            <pubDate>Wed, 10 Oct 2007 19:00:36 +0100</pubDate>
            <guid isPermaLink="false">941863</guid>        </item>
        <item>
            <title>HIV and the Bubonic Plague: Economic Boon?</title>
            <link>http://www.medworm.com/index.php?rid=891654&amp;cid=t_128449_135_f&amp;fid=35272&amp;url=http%3A%2F%2Fslimconomy.blogspot.com%2F2007%2F09%2Fhiv-and-bubonic-plague-economic-boon.html</link>
            <description>Just about everyone in Western society is familiar with &quot;The Plague&quot;, which was the Bubonic Plague of the 1300's. HIV is our newest plague, or perhaps Plague 2.0. Will it become, an economic boon? How cruel is that? To think of something so vicious as eventually becoming an economic boon? It's certainly an economic benefit to many organizations as discussed briefly in my last post.Looking at current global sociopolitical events, tied in with the ongoing spread and cost of HIV, there are, I find, some remarkable, and frightening, similarities. In the 1300's, Plague 1.0 saw everyone leaving cities and heading to the country. Political infrastructures were also collapsing as empires re-aligned themselves and there was no hegemony in the world. The British Empire was yet to come to prominence....</description>
            <author>Slimconomy</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=891654</comments>
            <pubDate>Fri, 21 Sep 2007 19:23:00 +0100</pubDate>
            <guid isPermaLink="false">891654</guid>        </item>
        <item>
            <title>Liver cancer doubled in one decade</title>
            <link>http://www.medworm.com/index.php?rid=706563&amp;cid=t_128449_87_f&amp;fid=34865&amp;url=http%3A%2F%2Fwww.thecancerblog.com%2F2007%2F06%2F30%2Fliver-cancer-doubled-in-one-decade%2F</link>
            <description>Filed under: Liver Cancer, Research, Obesity, SurgeryLiver cancer experts attribute the rise in HCC, a highly aggressive cancer sometimes called hepatoma, to an increase decades ago in chronic infection with hepititis C &amp; B and also chronic alcohol consumption. Worldwide liver cancer affects 700,000 people with 18,000 Americans diagnosed in 2006 and over 19,000 estimated to be diagnosed in 2007. The increase of this disease in the United States has doubled in one decade and over 16,000 people are estimated to die from the disease this year.The rise in the United States is expected to increase. There are now 1.4 million people in the United States infected with HBV and 4 million are infected with HCV. Growing evidence suggests two other diseases now increasingly common in the United Sta...</description>
            <author>The Cancer Blog</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=706563</comments>
            <pubDate>Sat, 30 Jun 2007 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">706563</guid>        </item>
    </channel>
</rss>

